XM does not provide services to residents of the United States of America.

Financials lead Australia shares higher; local jobs data eyed



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Financials lead Australia shares higher; local jobs data eyed</title></head><body>

June 13 (Reuters) -Australian shares edged higher to snap from a two-day losing streak on Thursday, led by gains in heavyweight financials, while investors keenly awaited domestic jobs data for further clarity on the central bank's monetary policy stance.

The S&P/ASX 200 index .AXJO rose 0.6% to 7,763 points by 0030 GMT. The benchmark closed 0.5% lower on Wednesday.

Investors awaited the local unemployment data for May, due at 0130 GMT, for cues on the Reserve Bank of Australia's (RBA) monetary policy trajectory.

The central bank's two-day monetary policy meeting is scheduled for next week.

Globally, investors exercised caution after the U.S. Federal Reserve left interest rates unchanged and projected only one interest rate cut this year. MKTS/GLOB

Back in Sydney, interest rate-sensitive financial stocks .AXFJ led the charge to rise as much as 0.7%, with the "Big Four" banks gaining between 0.8% and 1.2%.

Gold stocks .AXGD added as much as 1.6% on the back of stronger bullion prices. GOL/

Gold miners Evolution Mining EVN.AX and Northern Star Resources NST.AX gained as much as 1.9% and 1.2%, respectively.

Energy stocks .AXEJ tracked gains in oil prices and advanced as much as 0.7%. O/R

Energy majors Woodside Energy WDS.AX and Santos STO.AX gained as much as 0.4% and 0.9%, respectively.

Bucking the trend, mining stocks .AXMM shed as much as 0.2% as iron ore prices struggled for direction. IRONORE/

In company news, Qantas Airways QAN.AX said it will acquire the remaining 49% stake in online travel business TripADeal for A$211 million ($140.6 million) as the airline seeks to capitalize on strong demand for holiday bookings. Shares of Qantas were last up 0.8%.

Australia's competition regulator highlighted potential competition concerns over Sigma Healthcare's SIG.AX proposed merger with Chemist Warehouse Group to form an A$8.8 billion entity. Shares of the company fell as much as 10.4% to A$1.08, theirlowest level since Feb. 27.

New Zealand's S&P/NZX 50 index .NZ50 rose 0.4% to 11,793.48 points. The benchmark is set to snap a five-day losing streak.




Reporting by Sherin Sunny in Bengaluru; Editing by Eileen Soreng

For more information on DIARIES & DATA: U.S. earnings diary RESF/US Wall Street Week Ahead .N/O Global Economy Week Ahead DATA/ ................................................................ For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.